Neumora Therapeutics, Inc. (NMRA)
NASDAQ: NMRA · Real-Time Price · USD
1.650
0.00 (0.00%)
At close: Jul 30, 2026, 4:00 PM EDT
1.650
0.00 (0.00%)
After-hours: Jul 30, 2026, 4:10 PM EDT
Neumora Therapeutics Market Cap
Neumora Therapeutics has a market cap or net worth of $305.72 million as of July 30, 2026. Its market cap has decreased by -13.69% in one year.
Market Cap
305.72M
Enterprise Value
212.02M
1-Year Change
-13.69%
Ranking
Category
Stock Price
$1.65
ChartMarket Cap Chart
Since the IPO on September 15, 2023, Neumora Therapeutics's market cap has decreased from $2.58B to $305.72M, a decrease of -88.16%. That is a compound annual growth rate of -52.41%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 30, 2026 | 305.72M | 0.50% |
| Dec 31, 2025 | 304.19M | -82.24% |
| Dec 31, 2024 | 1.71B | -34.22% |
| Dec 29, 2023 | 2.60B | 0.79% |
| Sep 15, 2023 | 2.58B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Abeona Therapeutics | 343.11M |
| Rocket Pharmaceuticals | 342.87M |
| Zentalis Pharmaceuticals | 328.88M |
| Vicore Pharma Holding AB | 321.73M |
| Lyell Immunopharma | 318.31M |
| Vanda Pharmaceuticals | 310.30M |
| Foghorn Therapeutics | 301.20M |
| Agenus | 295.37M |